Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

223 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.
Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. Visser K, et al. Ann Rheum Dis. 2010 Jul;69(7):1333-7. doi: 10.1136/ard.2009.121160. Epub 2010 May 24. Ann Rheum Dis. 2010. PMID: 20498212 Clinical Trial.
Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.
Wevers-de Boer KV, Heimans L, Visser K, Kälvesten J, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Steup-Beekman M, de Buck MP, de Sonnaville PB, Huizinga TW, Allaart CF. Wevers-de Boer KV, et al. Among authors: visser k. Ann Rheum Dis. 2015 Feb;74(2):341-6. doi: 10.1136/annrheumdis-2013-203749. Epub 2013 Nov 27. Ann Rheum Dis. 2015. PMID: 24285491 Clinical Trial.
A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
Heimans L, Wevers-de Boer KV, Visser K, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Speyer I, de Buck MP, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF. Heimans L, et al. Among authors: visser k. Ann Rheum Dis. 2014 Jul;73(7):1356-61. doi: 10.1136/annrheumdis-2013-203243. Epub 2013 May 28. Ann Rheum Dis. 2014. PMID: 23716067 Clinical Trial.
Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.
Dirven L, Visser K, Klarenbeek NB, Ewals JA, Han KH, Peeters AJ, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. Dirven L, et al. Among authors: visser k. Scand J Rheumatol. 2012 Feb;41(1):15-9. doi: 10.3109/03009742.2011.594964. Epub 2011 Nov 21. Scand J Rheumatol. 2012. PMID: 22103436
Use of methotrexate in undifferentiated arthritis.
Visser K, Allaart CF, Huizinga TW. Visser K, et al. Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S117-21. Epub 2010 Oct 28. Clin Exp Rheumatol. 2010. PMID: 21044444 Review.
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.
Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Murphy G, Østergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M. Visser K, et al. Ann Rheum Dis. 2009 Jul;68(7):1086-93. doi: 10.1136/ard.2008.094474. Epub 2008 Nov 25. Ann Rheum Dis. 2009. PMID: 19033291 Free PMC article.
223 results